Je was op zoek naar: pjelonefrite (Maltees - Engels)

urosepsis u pjelonefrite
urosepsis and pyelonephritis

il-kliewi (pjelonefrite);
the kidneys (pyelonephritis);

- il- pjelonefrite hija sikwit assoċjata mal- batterjemija.
- pyelonephritis is often associated with bacteraemia.

- il- pjelonefrite ħafna drabi tkun assoċjata ma 'batterjemija.
- pyelonephritis is often associated with bacteraemia.

il-pjelonefrite ma kinitx komuni u seħħet bi frekwenza simili għal tal-kontroll.
pyelonephritis was uncommon and occurred at a similar frequency to control.

infezzjoni kkumplikata fl-apparat tal-awrina (cuti), inkluż il-pjelonefrite
complicated urinary tract infection (cuti), including pyelonephritis

l- istess oġġezzjonijet huma ovvjament validi għat- trattament orali ta 'pjelonefrite mhux kumplikata.
the same objections are obviously valid for the oral treatment of uncomplicated pyelonephritis.

pazjent wieħed fil-grupp saxagliptin kif ukoll dapagliflozin kif ukoll metformin esperjenza pjelonefrite sae u waqqaf il-kura.
one patient in the saxagliptin plus dapagliflozin plus metformin group experienced an sae of pyelonephritis and discontinued treatment.

- il- pjelonefrite kumplikata tista 'tiġi ttrattata b' formulazzjonijiet orali jew intravenużi (skont ir -
- complicated pyelonephritis can be treated orally or intravenously (according to local treatment

konkluŻjonijiet xjentifiĊi u raĠunijiet ippreŻentata mill- emea gĦat- tneĦĦija tal- indikazzjoni terapewtika "pjelonefrite akuta u kronika kumplikata" konkluŻjonijiet xjentifiĊi
scientific conclusions and grounds for the removal of the therapeutic indication “ acute and chronic complicated pyelonephritis” presented by the emea scientific conclusions

19 • infezzjonijiet bronko- pulmonari f’ fibrożi ċistika ikkaġunata minn pseudomonas aeruginosa. • infezzjonijiet tal- passaġġi awrinarji ikkumplikati u pjelonefrite • anthrax li jittieħed man- nifs (profilassi wara l- esponiment u intenzjoni kurattiva)
indications for oral and intravenous formulations in children and adolescents: • broncho-pulmonary infections in cystic fibrosis caused by pseudomonas aeruginosa. • complicated urinary tract infections and pyelonephritis • inhalation anthrax (post-exposure prophylaxis and curative intent)